First head-to-head study in people living with obesity shows tirzepatide results in around 50% more weight loss than semaglutide A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an average weight loss of 20.2%, 47% higher than the 13.7% average weight loss for semaglutide
How a Provider-Led GLP-1 Program Works From Home Step One: Complete a Medical Intake A good program starts with more than your height and weight
A typical split protocol would involve 0.25 mg in the morning and 0.25 mg in the evening
El problema con la narrativa de la medicacin La explosin de medicamentos con GLP-1 ha creado una impresin engaosa: que el GLP-1 es algo que hay que inyectarse porque el cuerpo no produce lo suficiente
This article explains practical, evidence-based ways to use turmeric for weight loss, including dosage, ideal timing, synergistic pairings, and daily preparation methods that maximize absorption and safety